Compare Procter & Gamble Health with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs IPCA LABS - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH IPCA LABS PROCTER & GAMBLE HEALTH/
IPCA LABS
 
P/E (TTM) x 52.2 21.6 241.7% View Chart
P/BV x 4.7 4.2 112.8% View Chart
Dividend Yield % 10.0 0.1 8,957.7%  

Financials

 PROCTER & GAMBLE HEALTH   IPCA LABS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
IPCA LABS
Mar-18
PROCTER & GAMBLE HEALTH/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3,549695 510.4%   
Low Rs1,301400 325.3%   
Sales per share (Unadj.) Rs511.4260.2 196.6%  
Earnings per share (Unadj.) Rs61.319.0 323.1%  
Cash flow per share (Unadj.) Rs74.033.1 223.9%  
Dividends per share (Unadj.) Rs440.001.00 44,000.0%  
Dividend yield (eoy) %18.10.2 9,937.0%  
Book value per share (Unadj.) Rs927.8213.0 435.5%  
Shares outstanding (eoy) m16.60126.20 13.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.1 225.3%   
Avg P/E ratio x39.628.9 137.1%  
P/CF ratio (eoy) x32.816.6 197.8%  
Price / Book Value ratio x2.62.6 101.7%  
Dividend payout %717.95.3 13,619.8%   
Avg Mkt Cap Rs m40,25769,120 58.2%   
No. of employees `0001.113.3 8.6%   
Total wages/salary Rs m1,3137,359 17.8%   
Avg. sales/employee Rs Th7,486.72,477.4 302.2%   
Avg. wages/employee Rs Th1,157.6555.2 208.5%   
Avg. net profit/employee Rs Th897.2180.6 496.7%   
INCOME DATA
Net Sales Rs m8,49032,836 25.9%  
Other income Rs m244418 58.3%   
Total revenues Rs m8,73433,254 26.3%   
Gross profit Rs m1,4824,505 32.9%  
Depreciation Rs m2111,777 11.9%   
Interest Rs m0240 0.0%   
Profit before tax Rs m1,5142,905 52.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563511 110.1%   
Profit after tax Rs m1,0172,394 42.5%  
Gross profit margin %17.513.7 127.2%  
Effective tax rate %37.117.6 211.2%   
Net profit margin %12.07.3 164.4%  
BALANCE SHEET DATA
Current assets Rs m15,34319,455 78.9%   
Current liabilities Rs m1,96010,076 19.5%   
Net working cap to sales %157.628.6 551.9%  
Current ratio x7.81.9 405.4%  
Inventory Days Days4998 49.8%  
Debtors Days Days2867 42.5%  
Net fixed assets Rs m1,20920,260 6.0%   
Share capital Rs m166252 65.8%   
"Free" reserves Rs m15,23526,633 57.2%   
Net worth Rs m15,40126,886 57.3%   
Long term debt Rs m02,340 0.0%   
Total assets Rs m17,59541,173 42.7%  
Interest coverage xNM13.1-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.50.8 60.5%   
Return on assets %5.86.4 90.4%  
Return on equity %6.68.9 74.2%  
Return on capital %10.310.8 95.3%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m1,63615,642 10.5%   
Fx outflow Rs m4,3684,884 89.4%   
Net fx Rs m-2,73210,759 -25.4%   
CASH FLOW
From Operations Rs m-1,3043,411 -38.2%  
From Investments Rs m12,697-1,354 -937.8%  
From Financial Activity Rs m-301-1,304 23.0%  
Net Cashflow Rs m11,093753 1,472.8%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 11.4 159.6%  
FIIs % 1.0 25.3 4.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.4 167.2%  
Shareholders   28,591 36,892 77.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   PLETHICO PHARMA  BIOCON   FULFORD INDIA  ALKEM LABORATORIES  AJANTA PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Oct 16, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS